Eventide Asset Management, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$6.05B
Q ending 2026-03-31
Prior quarter
$6.40B
Q ending 2025-12-31
Change
-5.5% QoQ · +20.5% YoY
Positions
278
reported holdings
Largest positions
Top 100 of 278 reported positions by value, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Guardant Health Inc | GH | Shares | $218.1M | 2.4M |
| Trane Technologies Plc | Shares | $169.0M | 407K | |
| Lam Research Corp | LRCX | Shares | $146.6M | 688K |
| Mirum Pharmaceuticals Inc | MIRM | Shares | $130.1M | 1.4M |
| Targa Res Corp | TRGP | Shares | $125.8M | 502K |
| Xometry Inc | XMTR | Shares | $120.8M | 3.0M |
| Ge Vernova Inc | GEV | Shares | $115.6M | 133K |
| Old Dominion Freight Line In | ODFL | Shares | $115.5M | 592K |
| Scholar Rock Hldg Corp | SRRK | Shares | $107.9M | 2.2M |
| Argenx Se | ARGX | Shares | $91.7M | 126K |
| Asml Hldg Nv | Shares | $89.9M | 68K | |
| Irhythm Holdings Inc | IRTC | Shares | $89.8M | 761K |
| Insmed Inc | INSM | Shares | $89.3M | 546K |
| Axsome Therapeutics Inc. | AXSM | Shares | $87.8M | 520K |
| Vaxcyte Inc | PCVX | Shares | $79.8M | 1.4M |
| Entergy Corp New | ETR | Shares | $76.5M | 683K |
| Vistra Corp | VST | Shares | $74.0M | 493K |
| United Rentals Inc | URI | Shares | $71.2M | 98K |
| Liberty Energy Inc | LBRT | Shares | $69.2M | 2.4M |
| Toast Inc | TOST | Shares | $66.0M | 2.5M |
| Mettler Toledo International | MTD | Shares | $64.0M | 51K |
| Monolithic Pwr Sys Inc | MPWR | Shares | $63.4M | 58K |
| Royalty Pharma Plc | Shares | $62.6M | 1.3M | |
| Nvent Elec Plc | Shares | $61.6M | 524K | |
| Williams Cos Inc | WMB | Shares | $60.5M | 832K |
| Nasdaq Inc | NDAQ | Shares | $60.2M | 712K |
| Generac Hldgs Inc | GNRC | Shares | $59.9M | 307K |
| Beta Bionics Inc | BBNX | Shares | $59.6M | 5.9M |
| D R Horton Inc | DHI | Shares | $59.0M | 431K |
| Kla Corp | KLAC | Shares | $57.8M | 40K |
| Belite Bio Inc | BLTE | Shares | $57.0M | 358K |
| Lattice Semiconductor Corp | LSCC | Shares | $56.6M | 611K |
| Prologis Inc. | PLD | Shares | $56.1M | 427K |
| Transmedics Group Inc | TMDX | Shares | $54.5M | 549K |
| Dt Midstream Inc | DTM | Shares | $54.1M | 402K |
| Nisource Inc | NI | Shares | $53.3M | 1.1M |
| Kymera Therapeutics Inc | KYMR | Shares | $52.2M | 627K |
| Rb Global Inc | RBA | Shares | $50.6M | 528K |
| Waste Connections Inc | WCN | Shares | $50.3M | 310K |
| Oreilly Automotive Inc | ORLY | Shares | $49.8M | 540K |
| Quanta Svcs Inc | PWR | Shares | $49.0M | 89K |
| Collegium Pharmaceutical Inc | COLL | Shares | $47.1M | 1.4M |
| Apogee Therapeutics Inc | APGE | Shares | $46.9M | 557K |
| Vulcan Matls Co | VMC | Shares | $46.2M | 170K |
| Nvidia Corporation | NVDA | Shares | $44.7M | 259K |
| Eastgroup Pptys Inc | EGP | Shares | $43.6M | 236K |
| Ionis Pharmaceuticals Inc | IONS | Shares | $43.2M | 575K |
| Steris Plc | Shares | $43.0M | 195K | |
| Palo Alto Networks Inc | PANW | Shares | $40.4M | 252K |
| Lowes Cos Inc | LOW | Shares | $40.2M | 171K |
| Rollins Inc | ROL | Shares | $40.2M | 753K |
| Element Solutions Inc | ESI | Shares | $39.8M | 1.2M |
| Ferguson Enterprises Inc | FERG | Shares | $39.3M | 169K |
| Huntington Bancshares Inc | HBAN | Shares | $39.3M | 2.5M |
| Chewy Inc | CHWY | Shares | $38.1M | 1.4M |
| Teradyne Inc | TER | Shares | $37.6M | 127K |
| Global E Online Ltd | Shares | $37.6M | 1.2M | |
| Talen Energy Corp | TLN | Shares | $37.4M | 117K |
| Fastenal Co | FAST | Shares | $36.9M | 798K |
| Abivax Sa | ABVX | Shares | $35.7M | 321K |
| Roper Technologies Inc | ROP | Shares | $33.8M | 96K |
| Houlihan Lokey Inc | HLI | Shares | $33.8M | 236K |
| Celldex Therapeutics Inc New | CLDX | Shares | $32.9M | 1.0M |
| Bridgebio Pharma Inc | BBIO | Shares | $32.5M | 437K |
| Applied Indl Technologies In | AIT | Shares | $32.1M | 121K |
| Cytokinetics Inc | CYTK | Shares | $31.6M | 479K |
| Trevi Therapeutics Inc | TRVI | Shares | $31.3M | 2.6M |
| Dexcom Inc | DXCM | Shares | $31.1M | 495K |
| Axon Enterprise Inc | AXON | Shares | $29.6M | 70K |
| Genedx Holdings Corp | WGS | Shares | $29.5M | 459K |
| Palvella Therapeutics Inc Ne | PVLA | Shares | $29.0M | 233K |
| Kestra Med Technologies Ltd | Shares | $28.8M | 1.4M | |
| Datadog Inc | DDOG | Shares | $28.3M | 240K |
| Celcuity Inc | CELC | Shares | $27.8M | 244K |
| Evommune Inc | EVMN | Shares | $27.8M | 1.2M |
| Intuitive Surgical Inc | ISRG | Shares | $27.6M | 60K |
| Msci Inc | MSCI | Shares | $27.5M | 51K |
| Baker Hughes Company | BKR | Shares | $26.7M | 438K |
| Mbx Biosciences Inc | MBX | Shares | $26.6M | 890K |
| Centessa Pharmaceuticals Plc | 260 | Shares | $26.5M | 668K |
| Sionna Therapeutics Inc | SION | Shares | $25.9M | 646K |
| Frontdoor Inc | FTDR | Shares | $25.7M | 486K |
| Eqt Corp | EQT | Shares | $25.5M | 400K |
| Sitime Corp | SITM | Shares | $25.4M | 74K |
| Revolution Medicines Inc | RVMD | Shares | $25.4M | 261K |
| Disc Medicine Inc | IRON | Shares | $25.3M | 396K |
| Cg Oncology Inc | CGON | Shares | $25.0M | 370K |
| Wec Energy Group Inc | WEC | Shares | $24.2M | 209K |
| Vertiv Holdings Co | VRT | Shares | $23.8M | 95K |
| Immix Biopharma Inc | IMMX | Shares | $23.2M | 2.5M |
| Arrowhead Pharmaceuticals In | ARWR | Shares | $23.2M | 370K |
| International Paper Co | IP | Shares | $23.0M | 645K |
| Ul Solutions Inc | ULS | Shares | $22.8M | 268K |
| Motorola Solutions Inc | MSI | Shares | $22.8M | 53K |
| Sherwin Williams Co | SHW | Shares | $22.8M | 71K |
| Pentair Plc | Shares | $22.5M | 260K | |
| Halliburton Co | HAL | Shares | $22.2M | 569K |
| Constellation Energy Corp | CEG | Shares | $22.1M | 78K |
| Ovid Therapeutics Inc | OVID | Shares | $22.0M | 9.9M |
| Adc Therapeutics Sa | Shares | $21.4M | 5.7M |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.